Loading
Life sciences · Interventional Study
ClinicalTrials.gov · November 4, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT05652218). This is a study registration, not published results. Lead sponsor: Inova Health Care Services. Recruitment status: ACTIVE_NOT_RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 21 participants (ACTUAL). Conditions: Left Ventricular Ejection Fraction, Heart Failure (HF), Left Bundle-Branch Block. Interventions: DEVICE: LB-CRT; DEVICE: BIV-CRT. Primary outcome measures: Change in myocardial performance index (MPI) as compared to Baseline , Baseline and 3 month treatment period after each pacing mode. Brief summary: Primary Objective - To determine if implantation of a permanent CRT pacing device (with LB-CRT, or conventional BiV-CRT with a coronary sinus LV lead) can improve electromechanical function, HF symptoms, and natriuretic peptide levels among patients with symptomatic HF, LVEF \> 35%, and LBBB.